Quarterly report [Sections 13 or 15(d)]

NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details)

v3.25.1
NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details) - shares
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Backstop Notes | Senior Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Percentage of common stock outstanding, issuable 9.90%  
Common stock issuable due to grants of RSUs with service only (i.e., time-vesting) conditions    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 882,886 1,037,219
Common stock issuable under the Backstop Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,920,007 1,920,007
Private placement warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 54,556 54,556